Shionogi Europe’s Post

🌍 Antimicrobial Resistance (AMR): A Global Health Challenge 🦠 As we mark World Antimicrobial Awareness Week (Nov 18-24), it’s time to confront some alarming facts about Antimicrobial Resistance (AMR)—a crisis that could redefine global healthcare. 💬 "Antimicrobial resistance is a ticking time bomb—if we don't act now, the cure for tomorrow's diseases may not exist." – Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. 🔎 Did you know? •By 2050, AMR could cause 10 million deaths annually, surpassing cancer deaths. •Misuse of antibiotics in humans and animals accelerates resistance, threatening the efficacy of 70% of current treatments. •700,000 people die each year from drug-resistant infections—a number expected to rise drastically without intervention. •The economic burden of AMR could reach $100 trillion globally if no action is taken. 💡 What can we do? 1️⃣ Only take antibiotics when prescribed. Misuse fuels resistance. 2️⃣ Educate your community about AMR's dangers. Awareness is key. 3️⃣ Advocate for global policy changes and support research into new treatments. 🚨 Preserve the Power of Antibiotics: Use them wisely, educate boldly, and take action today to secure the future of medicine. 🛡️ Together, we can prevent AMR from becoming the next health catastrophe. 📢 What steps are you taking to combat AMR? Join the conversation and help safeguard the future of medicine. Together, we can make a difference! 🔗 Share your thoughts below or join awareness campaigns in your region! #AMR #WorldAntimicrobialAwarenessWeek #GlobalHealth #PharmacyLeadership #SaveLives #IVPNNetwork

From the United Nations to the G7, antimicrobial resistance (AMR) has rightly been in the global health spotlight at many high-level meetings this year. At Shionogi we continue to focus our efforts on helping to address the urgent crisis of drug-resistant infection, through our scientific research and advocating for sustainable policy solutions. Recently, we worked with Euractiv on a Shionogi-supported special report to highlight some of the challenges we must face together to help tackle AMR - "Antimicrobial resistance fight needs more ambition, new alliances and strategies". We covered these three important areas in the report: • Dr Isao Teshirogi, President & CEO of Shionogi, highlights the urgent need for new antibiotics and the economic challenges in R&D. • Simona Falciai, General Manager of Shionogi Italia, shares insights after the G7 Health Ministers’ meeting, where Italy’s Minister of Health, Professor Orazio Schillaci, pledged to tackle market failures in AMR. • At the #EuropeanHealthSummit, Huw Tippett, CEO of Shionogi Europe, calls for a rethink of antibiotics business models. Find out more in the full Euractiv report here: https://lnkd.in/eh6mBM4B #AMR #GlobalHealth #Innovation  #PublicHealth #G7 #AMRHLM

Today is European Antibiotic Awareness Day, and as each year, we put the prudent use of antibiotics in the spotlight, to keep them working for the current and future generations. This EAAD we would like to, alongside with our partners at World Health Organization, give the floor to the people who have been directly affected by antimicrobial resistance and let them tell you their stories. You will meet Areti, Rosa, Yira and Gavin - each sharing their personal experiences with AMR, sending powerful messages about the simple steps each of us can take to make a difference. As each 18th November, ECDC is also sharing the latest data on antimicrobial consumption and resistance in the EU/EEA countries - showing the current scope of the problem. This time we are also joined by our trusty online ambassadors, who help us share the message about the burden of AMR and steps to reduce it on social media platforms across the EU, in a number of EU languages. 𝗬𝗼𝘂 𝗰𝗮𝗻 𝗳𝗶𝗻𝗱 𝗮𝗹𝗹 𝗼𝗳 𝘁𝗵𝗮𝘁, 𝗮𝗻𝗱 𝗺𝘂𝗰𝗵 𝗺𝗼𝗿𝗲 𝗼𝗻 𝗼𝘂𝗿 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝗘𝗔𝗔𝗗 𝘄𝗲𝗯𝘀𝗶𝘁𝗲 𝗵𝗲𝗿𝗲: https://bit.ly/EAAD2024 Follow our social media channels throughout the week to find out more about antimicrobial resistance, meet the brave patients sharing their stories, and get insights into the data side of the problem. Antimicrobial resistance is invisible. The patients are not. Hear their stories. #KeepAntibioticsWorking #EAAD #EAAD2024 #AntimicrobialResistance #WAAW #WAAW2024

Ahead of the World Health Assembly (#WHA77) next week, The Lancet has published a series of papers on 'Sustainable Access to Effective Antibiotics'.     I'm proud to have contributed to this important work that highlights the urgent need for global action on antimicrobial resistance (AMR): hubs.li/Q02xnk7n0   AMR is one of the greatest health challenges of our time. It threatens us all, however the most vulnerable are at the most risk.     If we don't prioritise action now, we will see a steady increase in the global death toll.    This week, we shared Wellcome Trust's recommendations for driving more ambitious action on AMR:  1. set a bold, unifying goal for reducing AMR  2. create a panel for scientific evidence and action  3. establish mechanisms to regularly review progress    High-level political events this year present a unique opportunity for global leaders to unite in a more effective, collective response to AMR.    To improve health and save lives, it must be informed by scientific evidence and establish clear targets and governance.    You can read more in our policy brief. https://lnkd.in/etawaiGc

Incentives should include payer reforms that recognize both individual and societal value of new antibiotic therapies.

Antimicrobial resistance ( AMR ) is indeed a public health concern . Despite the current efforts to Control AMR , both death rate and expenses have increased . To Combat this threat , a thorough understanding of the mechanisms and the driver behind this issue needs to be known . The key mechanisms of resistance are ; Modification or Destruction of antimicrobials , Reduction of access to the target , and Alteration of the target . These mechanisms may be Innate or Acquired from other microorganisms . A good knowledge of this will impact Antimicrobial stewardship to a great extent . Let's fight AMR together ! I appreciate and give credits to my team members Chidozie Onyeanusi, Blessing Umukoro , Gift Nwonu , Olamide Ilegbemi , Tolulope James Please kindly join and share your knowledge with us and register to AMR Awareness session https://lnkd.in/e79kiugM World Antimicrobial Resistance Awareness week by Pharma Incubation Hub cohort 6 Team 10 . #antimicrobialresistance #Antimicrobialresistanceawareness #Antimicrobialresistanceweek #educateadvocateactnow #GuardiansoftheMicrobialBalanceActTodaytoprotecttomorrow #StrengthinUnityAgainstAMR #pharmaIncubationHub

Gareth Morgan, Global Head of Portfolio Management and AMR Policy, took part in a recent AMR Industry Alliance’s meeting on antimicrobial resistance (#AMR). United Nations Member State representatives and AMR stakeholders convened to review priority actions needed to address this urgent public health threat in advance of the UN High Level Meeting (HLM), taking place this September. The HLM is an important opportunity for governments, international organizations, academia, civil society and industry to align on priorities and for the UN to approve an action-oriented political declaration to address AMR.  At the meeting, AMR Industry Alliance launched the industry’s “Call-to-Action” encouraging the UN Member States to commit to and advance bold, coordinated action on AMR. The meeting included panel discussions about repairing the market for antimicrobials, the importance of diagnostics, overcoming barriers to equitable access and strengthening responsible manufacturing. Gareth spoke about our work with Global Antibiotic R&D Partnership (GARDP) and Clinton Health Access Initiative, Inc. to address AMR.    Read more about the Alliance's call-to-action here: https://bit.ly/3V0gcVh  

Antimicrobial resistance(AMR) is indeed a public health concern. Despite the current efforts to Control AMR, both death rate and expenses have increased. To Combat this threat, a thorough understanding of the mechanisms and the driver behind this issue needs to be known. The key mechanisms of resistance are; Modification or Destruction of antimicrobials, Reduction of access to the target, and Alteration of the target. These mechanisms may be Innate or Acquired from other microorganisms. A good knowledge of this will impact Antimicrobial stewardship to a great extent. Let's fight AMR together! I appreciate and give credits to my team members Ebaa Yasir, Eugène Rusanganira, Priscilla Chisom Ugama, Tolulope James, Blessing Umukoro. https://lnkd.in/etGRzy_S AMR survey World Antimicrobial Resistance Awareness week by Pharma Incubation Hub cohort 6 Team 10. #WAMRWday2 #PIH #AMRfacts #fightAMRtogether

Our own Dr. Boumediene Soufi, Global AMR Program Lead, is participating in the 79th session of the UN General Assembly (UNGA 79), actively contributing to key sessions on antimicrobial resistance (AMR) and other critical global health issues. As the global leader in generic and biosimilar medicines, #Sandoz is committed to advancing its Purpose of pioneering access for patients. Engaging in these important global discussions with key stakeholders allows us to contribute to promoting responsible antibiotic use and fostering cross-sector collaboration to tackle the global health threat posed by AMR. Together, we are working towards a future where access to affordable and high-quality medicines is ensured for all and the global healthcare community unites to combat global public health threats, particularly #AMR. #UNGA79

One of the most pressing issues in healthcare today – and with direct implications for #Sandoz as the global leader in generic antibiotics – is antimicrobial resistance (AMR). The High-Level Meeting on #AMR occurs at a pivotal moment for global stakeholders to unite, discuss policies, and commit to action. Our participation in these high-level discussions will allow us to collaborate with other leaders, influence policy development, and help shape the global AMR strategy moving forward.